IMARC Group, a leading market research company, has recently releases report titled “Empty Capsules Market Report by Type (Gelatin Capsule, Non-gelatin Capsule), Raw Material (Pig Meat, Bovine Meat, Bone, Hydroxypropyl Methylcellulose (HPMC), and Others), Functionality (Immediate-release Capsules, Sustained-release Capsules, Delayed-release Capsules), Therapeutic Application (Antibiotic and Antibacterial Drugs, Vitamins and Dietary Supplements, Antacid and Antiflatulent Preparations, Cardiovascular Therapy Drugs, and Others), End User (Pharmaceutical Industry, Nutraceutical Industry, Cosmetics Industry, and Others), and Region 2024-2032”, Offers a comprehensive analysis of the industry, which comprises insights on the global empty capsules market.
How Big is the Empty Capsules Market?
The global empty capsules market size reached US$ 3.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.6% during 2024-2032.
Industry Overview of Empty Capsules
Empty capsules are stable shells that enclose medications in various forms, such as granules and pellets, for administration in the patient's body. They are commercially accessible in two types: gelatin and non-gelatin. Gelatin capsules, available as hard or soft variants, are animal-based shells derived from collagen found in pig meat, beef, and chicken connective tissues. In contrast, non-gelatin or vegetarian capsules are composed of a blend of starch and hydroxypropyl methylcellulose (HPMC). Presently, empty capsules are widely utilized in healthcare and therapeutic settings, serving a variety of applications.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/empty-capsules-market/requestsample
What are the growth prospects and trends in the empty capsules industry?
The increasing incidences of cardiovascular and chronic illnesses, as well as the growing older population, are driving the growth of the empty capsule market. Additionally, the introduction of capsule-in-capsule technology, which ensures gastrointestinal safety for patients who cannot swallow traditional capsule medication, contributes to market growth.
Furthermore, manufacturers' rising demand for immediate-release capsules for producing a wide range of medicinal products, including antibacterial drugs, antacids, inhalers, dietary supplements, painkillers, and antibiotics, fuels market expansion. The rapid expansion of the healthcare industry and the adoption of non-gelatin capsules like hydroxypropyl methylcellulose (HPMC) due to their transparency, moderate strength, and resistance to fat and oil properties are propelling the market growth.
Moreover, increased investments in research and development (R&D) activities within the healthcare sector to introduce innovative therapeutics and pharmaceutical drugs have a positive impact on market growth. Several other factors, such as easy access to advanced treatment options, strategic collaborations between gelatin manufacturers and empty capsule suppliers, and the growing demand for dietary supplements, immunity boosters, and medications create a favorable market outlook.
Leading Companies Operating in the Global Empty Capsules Industry:
- ACG Associated Capsules Pvt. Ltd.
- Bright Pharma Caps Inc.
- CapsCanada Corporation
- HealthCaps India Limited
- Lonza Group AG
- Medicaps Limited
- Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation)
- Nectar Lifesciences Limited
- Roxlor LLC
- Shanxi Guangsheng Medicinal Capsules Co. Ltd
- Snail Pharma Industry Co. Ltd
- Suheung Co. Ltd
- Sunil Healthcare Limited
Empty Capsules Market Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Type:
- Gelatin Capsule
- Non-gelatin Capsule
Breakup by Raw Material:
- Pig Meat
- Bovine Meat
- Bone
- Hydroxypropyl Methylcellulose (HPMC)
- Others
Breakup by Functionality:
- Immediate-release Capsules
- Sustained-release Capsules
- Delayed-release Capsules
Breakup by Therapeutic Application:
- Antibiotic and Antibacterial Drugs
- Vitamins and Dietary Supplements
- Antacid and Antiflatulent Preparations
- Cardiovascular Therapy Drugs
- Others
Breakup by End User:
- Pharmaceutical Industry
- Nutraceutical Industry
- Cosmetics Industry
- Others
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
